Evidence map›Paper›PMID 32326305›Full record

ArticleCancers2020

The Role of Anti-Angiogenics in Pre-Treated Metastatic

Fabio Gelsomino, Andrea Casadei-Gardini, Daniele Rossini, Alessandra Boccaccino, Gianluca Masi, Chiara Cremolini, Andrea Spallanzani, Massimo Giuseppe Viola, Ingrid Garajovà, Massimiliano Salati and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Fabio GelsominoDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Andrea Casadei-GardiniDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Daniele RossiniDepartment of Translational Research and New Technologies in Medicine, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56121 Pisa, Italy.
Alessandra BoccaccinoDepartment of Translational Research and New Technologies in Medicine, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56121 Pisa, Italy.ORCID 0000-0001-7242-4396
Gianluca MasiDepartment of Translational Research and New Technologies in Medicine, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56121 Pisa, Italy.
Chiara CremoliniDepartment of Translational Research and New Technologies in Medicine, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56121 Pisa, Italy.
Andrea SpallanzaniDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Massimo Giuseppe ViolaDepartment of Surgery, Card. G. Panico Hospital of Tricase, 73039 Tricase, Italy.
Ingrid GarajovàMedical Oncology Unit, University Hospital of Parma, 43121 Parma, Italy.
Massimiliano SalatiDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Maria Teresa EliaDepartment of Medical Oncology, Card. G. Panico Hospital of Tricase, 73039 Tricase, Italy.
Francesco CaputoDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Chiara SantiniDepartment of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121 Modena, Italy.
Alfredo FalconeDepartment of Translational Research and New Technologies in Medicine, Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56121 Pisa, Italy.
Stefano CascinuDepartment of Medical Oncology, Università Vita-Salute, San Raffaele Hospital IRCCS, 20019 Milan, Italy.
Emiliano TamburiniDepartment of Medical Oncology, Card. G. Panico Hospital of Tricase, 73039 Tricase, Italy.
University of Modena and Reggio Emilia · ITUniversity of Pisa · ITOspedale di Cattinara · ITUniversity of Parma · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-angiogenicsBRAF mutationchemotherapycolorectal cancerMSI-H

Identifiers

PMID32326305
PMCPMC7226019
OpenAlexW3018585354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.